$65.96
0.00 (0%)
Respironics, Inc. (RESP.DL)
CAPS Rating:
The Company designs, develops, manufactures and markets medical devices used for the treatment of patients suffering from sleep and respiratory disorders.
No players have picked RESP.DL yet. Tell us why you think RESP.DL will outperform or underperform the S&P 500.
RSS Headlines
Fool UK
